These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36041771)

  • 1. Canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study.
    Dugas EN; Poirier M; Basque D; Bouhamdani N; LeBreton L; Leblanc N
    BMJ Open; 2022 Aug; 12(8):e065005. PubMed ID: 36041771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Canadian guidelines and the interdisciplinary clinical capacity of Canada to diagnose fetal alcohol spectrum disorder.
    Clarren SK; Lutke J; Sherbuck M
    J Popul Ther Clin Pharmacol; 2011; 18(3):e494-9. PubMed ID: 22124027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based prevalence of fetal alcohol spectrum disorder in Canada.
    Popova S; Lange S; Poznyak V; Chudley AE; Shield KD; Reynolds JN; Murray M; Rehm J
    BMC Public Health; 2019 Jun; 19(1):845. PubMed ID: 31253131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of fetal alcohol spectrum disorder diagnosis in Canada.
    Popova S; Lange S; Burd L; Chudley AE; Clarren SK; Rehm J
    PLoS One; 2013; 8(4):e60434. PubMed ID: 23593216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal alcohol spectrum disorder diagnostic clinic capacity in Canadian Provinces and territories.
    Popova S; Dozet D; Temple V; McFarlane A; Cook J; Burd L
    PLoS One; 2024; 19(4):e0301615. PubMed ID: 38568995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of the first 1,400 patients receiving diagnostic evaluations for fetal alcohol spectrum disorder at the Washington State Fetal Alcohol Syndrome Diagnostic & Prevention Network.
    Astley SJ
    Can J Clin Pharmacol; 2010; 17(1):e132-64. PubMed ID: 20335648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Demographic and Neurocognitive Profile of Clients Diagnosed With Fetal Alcohol Spectrum Disorder in PATCHES Paediatrics Clinics Across Western Australia and the Northern Territory.
    Connor S; Tan KY; Pestell CF; Fitzpatrick JP
    Alcohol Clin Exp Res; 2020 Jun; 44(6):1284-1291. PubMed ID: 32333805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent classes of neurodevelopmental profiles and needs in children and adolescents with prenatal alcohol exposure.
    McLachlan K; Minhas M; Ritter C; Kennedy K; Joly V; Faitakis M; Cook J; Unsworth K; MacKillop J; Pei J
    Alcohol Clin Exp Res (Hoboken); 2023 Apr; 47(4):772-785. PubMed ID: 36799306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a Common Form for Consistent Collection and Reporting of FASD Data from Across Canada: A Feasibility Study.
    Clarren S; Halliwell CI; Werk CM; Sebaldt RJ; Petrie A; Lilley C; Cook J
    J Popul Ther Clin Pharmacol; 2015; 22(3):e211-28. PubMed ID: 26567605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-related differences among individuals assessed for fetal alcohol spectrum disorder in Canada.
    Flannigan K; Poole N; Cook J; Unsworth K
    Alcohol Clin Exp Res (Hoboken); 2023 Mar; 47(3):613-623. PubMed ID: 36932990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal alcohol spectrum disorders and access to regional center services in San Diego County.
    Montag AC; Jones KL; Del Campo M; Akshoomoff N; Coles CD; Kable JA; Hernandez JG; Chambers CD
    Alcohol Clin Exp Res; 2022 Oct; 46(10):1857-1864. PubMed ID: 36059261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deferred diagnosis in children assessed for fetal alcohol spectrum disorder.
    Flannigan K; Gill K; Pei J; Andrew G; Rajani H; McFarlane A; O'Riordan T; Symes B; Rasmussen C
    Appl Neuropsychol Child; 2019; 8(3):213-222. PubMed ID: 29432031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficulties in Daily Living Experienced by Adolescents, Transition-Aged Youth, and Adults With Fetal Alcohol Spectrum Disorder.
    McLachlan K; Flannigan K; Temple V; Unsworth K; Cook JL
    Alcohol Clin Exp Res; 2020 Aug; 44(8):1609-1624. PubMed ID: 32472600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing outcomes of children and youth with fetal alcohol spectrum disorder (FASD) in the child welfare system to those in other living situations in Canada: Results from the Canadian National FASD Database.
    Burns J; Badry DE; Harding KD; Roberts N; Unsworth K; Cook JL
    Child Care Health Dev; 2021 Jan; 47(1):77-84. PubMed ID: 33068027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building clinical capacity for fetal alcohol spectrum disorder diagnoses in western and northern Canada.
    Clarren SK; Lutke J
    Can J Clin Pharmacol; 2008; 15(2):e223-37. PubMed ID: 18544794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International survey of diagnostic services for children with Fetal Alcohol Spectrum Disorders.
    Peadon E; Fremantle E; Bower C; Elliott EJ
    BMC Pediatr; 2008 Apr; 8():12. PubMed ID: 18412975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characteristics of adults with fetal alcohol spectrum disorder in corrections: a Canadian case ascertainment study.
    McLachlan K; McNeil A; Pei J; Brain U; Andrew G; Oberlander TF
    BMC Public Health; 2019 Jan; 19(1):43. PubMed ID: 30626356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Canadian prenatal record forms integrate evidence-based guidelines for the diagnosis of a FASD?
    Premji SS; Semenic S
    Can J Public Health; 2009; 100(4):274-80. PubMed ID: 19722340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterising fetal alcohol spectrum disorder in Canada: a national database protocol study.
    Cook J; Unsworth K; Flannigan K
    BMJ Open; 2021 Sep; 11(9):e046071. PubMed ID: 34489270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FASD prevalence among children and youth: results from the 2019 Canadian Health Survey on Children and Youth.
    Palmeter S; Probert A; Lagacé C
    Health Promot Chronic Dis Prev Can; 2021 Sep; 41(9):272-276. PubMed ID: 34549919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.